935525-13-6 Usage
General Description
The chemical compound "(alphaS)-N-[(1S)-2-[[(5S)-4,5-Dihydro-3-methyl-4-oxo-3H-2,3-benzodiazepin-5-yl]amino]-1-methyl-2-oxoethyl]-3,5-difluoro-alpha-hydroxybenzeneacetamide" is a complex molecule that belongs to the class of benzodiazepines. It features a benzodiazepine ring structure and contains a difluoro-alpha-hydroxybenzeneacetamide group. The compound is a derivative of the psychoactive drug diazepam and is characterized by its diverse pharmacological properties. Its chemical structure and functional groups make it suitable for interaction with various biological targets, influencing neurotransmitter activity and neuronal excitability in the central nervous system. Research is ongoing to explore its potential therapeutic applications in the treatment of anxiety, insomnia, and other neurological disorders.
Check Digit Verification of cas no
The CAS Registry Mumber 935525-13-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,5,5,2 and 5 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 935525-13:
(8*9)+(7*3)+(6*5)+(5*5)+(4*2)+(3*5)+(2*1)+(1*3)=176
176 % 10 = 6
So 935525-13-6 is a valid CAS Registry Number.
935525-13-6Relevant articles and documents
Discovery of (S)-2-((S)-2-(3,5-difluorophenyl)-2-hydroxyacetamido)-N-((S,Z)-3-methyl-4-oxo-4,5-dihydro-3H-benzo[d][1,2]diazepin-5-yl)propanamide (BMS-433796): A γ-secretase inhibitor with Aβ lowering activity in a transgenic mouse model of Alzheimer's dis
Prasad,Zheng, Ming,Vig, Shikha,Bergstrom, Carl,Smith, David W.,Gao, Qi,Yeola, Suresh,Polson, Craig T.,Corsa, Jason A.,Guss, Valerie L.,Loo, Alice,Wang, Jian,Sleczka, Bogdan G.,Dangler, Charles,Robertson, Barbara J.,Hendrick, Joseph P.,Roberts, Susan B.,Barten, Donna M.
, p. 4006 - 4011 (2008/02/09)
We report on the design of benzodiazepinones as peptidomimetics at the carboxy terminus of hydroxyamides. Structure-activity relationships of diazepinones were investigated and orally active γ-secretase inhibitors were synthesized. Active metabolites cont
